"Angioedemas, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT.
| Descriptor ID |
D054179
|
| MeSH Number(s) |
C14.907.079.500 C16.320.078 C17.800.862.945.066.500 C20.543.480.904.066.500
|
| Concept/Terms |
Angioedemas, Hereditary- Angioedemas, Hereditary
- Angioneurotic Edema, Hereditary
- Angioneurotic Edemas, Hereditary
- Edema, Hereditary Angioneurotic
- Edemas, Hereditary Angioneurotic
- Hereditary Angioneurotic Edemas
- C1 Inhibitor Deficiency
- Hereditary Angioedemas
- Hereditary Angioneurotic Edema
- C1 Esterase Inhibitor Deficiency
- Angioedema, Hereditary
- Hereditary Angioedema
|
Below are MeSH descriptors whose meaning is more general than "Angioedemas, Hereditary".
Below are MeSH descriptors whose meaning is more specific than "Angioedemas, Hereditary".
This graph shows the total number of publications written about "Angioedemas, Hereditary" by people in this website by year, and whether "Angioedemas, Hereditary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Angioedemas, Hereditary" by people in Profiles.
-
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study. J Allergy Clin Immunol Pract. 2024 Jan; 12(1):201-211.e6.
-
The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Postgrad Med. 2021 Aug; 133(6):639-650.
-
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1793-1802.e2.
-
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):2035-2038.
-
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema. Clin Exp Allergy. 2018 10; 48(10):1325-1332.
-
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728.
-
Recurrent attacks of hereditary angioedema: a case of delayed diagnosis. Allergy Asthma Proc. 2011 Sep-Oct; 32 Suppl 1:23-26.
-
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010 Aug 05; 363(6):513-22.
-
When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol. 2009 May; 102(5):366-72.